TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Millions of children in North America receive an annual flu vaccination, many of whom are at risk of experiencing severe distress. Children frequently use technologically advanced devices such as computers and cell phones. Based on this familiarity, the investigators introduced another sophisticated device - a humanoid robot to- interact with children during their vaccination. The investigators hypothesized that these children would experience less distress than children who did not have this interaction.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: pillow | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: pillow; Assigned to Arm(s): 1
B: Arm Label: Buzzy® device; Type: EXPERIMENTAL; Interventions: Device: Buzzy® device | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Buzzy® device; Assigned to Arm(s): Buzzy® device
C: Arm Label: music; Type: EXPERIMENTAL; Interventions: Behavioral: music | Arm Label: Standard care; Type: OTHER; Interventions: Behavioral: music | Intervention Type: BEHAVIORAL; Name: music; Assigned to Arm(s): Standard care, music
D: Arm Label: humanoid robot distration; Type: N/A; Interventions: N/A | Arm Label: control; Type: N/A; Interventions: N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Brief Summary: The purpose of this study is to evaluate the efficacy of paliperidone palmitate 3 month formulation (PP3M) compared with placebo in delay of the time to first occurrence of relapse of the symptoms of schizophrenia.


Options:
A: Intervention Type: DRUG; Name: Paliperidone ER; Assigned to Arm(s): N/A
B: Arm Label: Paliperidone palmitate 3-month (PP3M); Type: EXPERIMENTAL; Interventions: Drug: PP3M 175 mg eq., Drug: PP3M 263 mg eq., Drug: PP3M 350 mg eq., Drug: PP3M 525 mg eq. | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (20% Intralipid emulsion) | Intervention Type: DRUG; Name: PP3M 175 mg eq.; Assigned to Arm(s): Paliperidone palmitate 3-month (PP3M) | Intervention Type: DRUG; Name: PP3M 263 mg eq.; Assigned to Arm(s): Paliperidone palmitate 3-month (PP3M) | Intervention Type: DRUG; Name: PP3M 350 mg eq.; Assigned to Arm(s): Paliperidone palmitate 3-month (PP3M) | Intervention Type: DRUG; Name: PP3M 525 mg eq.; Assigned to Arm(s): Paliperidone palmitate 3-month (PP3M) | Intervention Type: DRUG; Name: Placebo (20% Intralipid emulsion); Assigned to Arm(s): Placebo
C: Arm Label: Cariprazine 3mg; Type: EXPERIMENTAL; Interventions: Drug: Cariprazine | Arm Label: Cariprazine 6mg; Type: EXPERIMENTAL; Interventions: Drug: Cariprazine | Arm Label: Aripiprazole 10mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aripiprazole | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Cariprazine; Assigned to Arm(s): Cariprazine 3mg, Cariprazine 6mg | Intervention Type: DRUG; Name: Aripiprazole; Assigned to Arm(s): Aripiprazole 10mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: 001; Type: EXPERIMENTAL; Interventions: Drug: Paliperidone Palmitate | Arm Label: 002; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 002 | Intervention Type: DRUG; Name: Paliperidone Palmitate; Assigned to Arm(s): 001

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective Study of the Feedback From an Adherence Monitor on Asthma Control
Brief Summary: Inhaled medications are the mainstay of the therapeutic management of respiratory disorders. Considered by many to be 'simple' and 'easy' to use, clinicians are aware that inhalers are often improperly used. However, there is no tool that can detect and record errors in either the timing or the method dose administration

The investigators designed a device that makes an acoustic record each time an inhaler is used. Opening the device makes an acoustic file which is recorded, this file is "time-stamped" which means that the timing of drug administration is recorded. When the device is retrieved and acoustic analysis performed, the steps involved in using the inhaler can be determined. Hence, the subjects inhaler technique is assessed and errors in the inhaler use identified. Together this means that errors in inhaler technique and timing of use can be quantified.

In this study the investigators attached the device to a discus dry powder inhaler. In order to eliminate the behavioral component of adherence and identify the mechanical issues associated with effective inhaler use the investigators studied subjects who were already in Hospital and already prescribed a discus inhaler. The investigators hypothesized that the device would identify which errors in technique were the most common and that this would provide insight into how these errors might be eliminated.


Options:
A: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile phone technology | Intervention Type: BEHAVIORAL; Name: Mobile phone technology; Assigned to Arm(s): 2
B: Arm Label: CHESS + Case Mgt; Type: EXPERIMENTAL; Interventions: Behavioral: CHESS Internet telehealth | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: CHESS Internet telehealth; Assigned to Arm(s): CHESS + Case Mgt
C: Arm Label: Active Feedback; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Feedback | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Active Feedback | Intervention Type: BEHAVIORAL; Name: Active Feedback; Assigned to Arm(s): Active Feedback, Control
D: Arm Label: Portal training and home visits; Type: EXPERIMENTAL; Interventions: Behavioral: Portal training and home visits | Arm Label: portal training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Portal training | Intervention Type: BEHAVIORAL; Name: Portal training and home visits; Assigned to Arm(s): Portal training and home visits | Intervention Type: BEHAVIORAL; Name: Portal training; Assigned to Arm(s): portal training

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective Study of the Feedback From an Adherence Monitor on Asthma Control
Brief Summary: Inhaled medications are the mainstay of the therapeutic management of respiratory disorders. Considered by many to be 'simple' and 'easy' to use, clinicians are aware that inhalers are often improperly used. However, there is no tool that can detect and record errors in either the timing or the method dose administration

The investigators designed a device that makes an acoustic record each time an inhaler is used. Opening the device makes an acoustic file which is recorded, this file is "time-stamped" which means that the timing of drug administration is recorded. When the device is retrieved and acoustic analysis performed, the steps involved in using the inhaler can be determined. Hence, the subjects inhaler technique is assessed and errors in the inhaler use identified. Together this means that errors in inhaler technique and timing of use can be quantified.

In this study the investigators attached the device to a discus dry powder inhaler. In order to eliminate the behavioral component of adherence and identify the mechanical issues associated with effective inhaler use the investigators studied subjects who were already in Hospital and already prescribed a discus inhaler. The investigators hypothesized that the device would identify which errors in technique were the most common and that this would provide insight into how these errors might be eliminated.


Options:
A: Intervention Type: DEVICE; Name: electronic medication monitoring system; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: parent-adolescent communication and problem-solving skills; Assigned to Arm(s): N/A
B: Arm Label: I; Type: EXPERIMENTAL; Interventions: Behavioral: Feedback of patient adherence information | Arm Label: II; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active control group | Intervention Type: BEHAVIORAL; Name: Feedback of patient adherence information; Assigned to Arm(s): I | Intervention Type: BEHAVIORAL; Name: Active control group; Assigned to Arm(s): II
C: Arm Label: Active Feedback; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Feedback | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Active Feedback | Intervention Type: BEHAVIORAL; Name: Active Feedback; Assigned to Arm(s): Active Feedback, Control
D: Arm Label: Automated Phone-Based Refill Reminders; Type: EXPERIMENTAL; Interventions: Behavioral: Automated Phone-Based Refill Reminders | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Automated Phone-Based Refill Reminders; Assigned to Arm(s): Automated Phone-Based Refill Reminders

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: RAPID: Reducing Pain; Preventing Depression
Brief Summary: The primary question addressed by this prevention study is to explore if improving pain and disability reduces episodes of Major Depression among seniors with knee osteoarthritis (OA) and mild depressive symptoms.


Options:
A: Arm Label: MWM treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: MWM Treatment | Arm Label: MWM sham; Type: SHAM_COMPARATOR; Interventions: Other: MWM Sham | Intervention Type: OTHER; Name: MWM Treatment; Assigned to Arm(s): MWM treatment | Intervention Type: OTHER; Name: MWM Sham; Assigned to Arm(s): MWM sham
B: Arm Label: Intervention to placebo; Type: OTHER; Interventions: Device: Patellofemoral realigning knee brace, Device: Non-aligning knee brace | Arm Label: Placebo to intervetion; Type: OTHER; Interventions: Device: Patellofemoral realigning knee brace, Device: Non-aligning knee brace | Intervention Type: DEVICE; Name: Patellofemoral realigning knee brace; Assigned to Arm(s): Intervention to placebo, Placebo to intervetion | Intervention Type: DEVICE; Name: Non-aligning knee brace; Assigned to Arm(s): Intervention to placebo, Placebo to intervetion
C: Arm Label: exercise; Type: ACTIVE_COMPARATOR; Interventions: Other: Exercise | Arm Label: exercise + manual therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Exercise, Other: manual therapy | Arm Label: exercise + booster; Type: EXPERIMENTAL; Interventions: Other: Exercise | Arm Label: exercise + manual therapy + booster; Type: EXPERIMENTAL; Interventions: Other: Exercise, Other: manual therapy | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): exercise, exercise + booster, exercise + manual therapy, exercise + manual therapy + booster | Intervention Type: OTHER; Name: manual therapy; Assigned to Arm(s): exercise + manual therapy, exercise + manual therapy + booster
D: Arm Label: Physical Therapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Physical Therapy for knee OA | Arm Label: Cognitive Behavioral Therapy for Pain; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy for Pain CBT-P | Arm Label: Enhanced Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Other: Enhanced Treatment as Usual | Intervention Type: PROCEDURE; Name: Physical Therapy for knee OA; Assigned to Arm(s): Physical Therapy | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy for Pain CBT-P; Assigned to Arm(s): Cognitive Behavioral Therapy for Pain | Intervention Type: OTHER; Name: Enhanced Treatment as Usual; Assigned to Arm(s): Enhanced Treatment as Usual

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Early Pharmacological Intervention to Prevent Delirium: Haloperidol Prophylaxis in Older Emergency Department Patients
Brief Summary: The investigators propose a multicenter, randomized, double-blinded, placebo-controlled trial to study the effect of additive low-dose haloperidol prophylaxis on top of exciting care in a general population of older patients (age 70 years and over) acutely admitted to the hospital through the emergency department (ED) for general medicine and surgical specialties, and who are at-risk for developing in-hospital delirium on admission according to the VMS delirium risk questions (one or more positive answers out of three questions).

The investigators hypothesize that this intervention will reduce the incidence of in-hospital delirium as well as duration and severity of delirium.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Bispectral index protocol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: End tidal anesthetic gas-guided | Intervention Type: BEHAVIORAL; Name: Bispectral index protocol; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: End tidal anesthetic gas-guided; Assigned to Arm(s): 2
B: Arm Label: Combined Epi-GA/PCEA; Type: EXPERIMENTAL; Interventions: Procedure: Combined Epi-GA/PCEA | Arm Label: GA/PCIA; Type: ACTIVE_COMPARATOR; Interventions: Procedure: GA/PCIA | Intervention Type: PROCEDURE; Name: Combined Epi-GA/PCEA; Assigned to Arm(s): Combined Epi-GA/PCEA | Intervention Type: PROCEDURE; Name: GA/PCIA; Assigned to Arm(s): GA/PCIA
C: Arm Label: Inhalational anesthetic; Type: ACTIVE_COMPARATOR; Interventions: Drug: Inhalational anesthetic | Arm Label: Intravenous anesthetic, propofol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Intravenous anesthetic, propofol | Intervention Type: DRUG; Name: Inhalational anesthetic; Assigned to Arm(s): Inhalational anesthetic | Intervention Type: DRUG; Name: Intravenous anesthetic, propofol; Assigned to Arm(s): Intravenous anesthetic, propofol
D: Arm Label: Investigational medicinal product; Type: ACTIVE_COMPARATOR; Interventions: Drug: Haloperidol | Arm Label: Placebo group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Haloperidol; Assigned to Arm(s): Investigational medicinal product | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dose-Response of Manipulation for Cervicogenic Headache
Brief Summary: This study will determine the number of visits to a chiropractor for spinal manipulation and light massage necessary for the optimal relief of cervicogenic headache (headache with associated neck pain). Effectiveness of care will also be determined.


Options:
A: Arm Label: High dose spinal manipulation; Type: EXPERIMENTAL; Interventions: Other: Spinal Manipulation | Arm Label: Moderate dose spinal manipulation; Type: EXPERIMENTAL; Interventions: Other: Spinal Manipulation, Other: Light Massage | Arm Label: Low dose spinal manipulation; Type: EXPERIMENTAL; Interventions: Other: Spinal Manipulation, Other: Light Massage | Arm Label: High dose massage; Type: OTHER; Interventions: Other: Light Massage | Intervention Type: OTHER; Name: Spinal Manipulation; Assigned to Arm(s): High dose spinal manipulation, Low dose spinal manipulation, Moderate dose spinal manipulation | Intervention Type: OTHER; Name: Light Massage; Assigned to Arm(s): High dose massage, Low dose spinal manipulation, Moderate dose spinal manipulation
B: Arm Label: Auto-acupressure; Type: EXPERIMENTAL; Interventions: Other: Auto-acupressure | Arm Label: Conventional treatment; Type: OTHER; Interventions: Other: Conventional treatment | Intervention Type: OTHER; Name: Auto-acupressure; Assigned to Arm(s): Auto-acupressure | Intervention Type: OTHER; Name: Conventional treatment; Assigned to Arm(s): Conventional treatment
C: Arm Label: Group I Experimental: thoracic manipulation; Type: EXPERIMENTAL; Interventions: Other: Thoracic manipulation | Arm Label: Group II Control; Type: ACTIVE_COMPARATOR; Interventions: Other: conventional pt protocol | Intervention Type: OTHER; Name: Thoracic manipulation; Assigned to Arm(s): Group I Experimental: thoracic manipulation | Intervention Type: OTHER; Name: conventional pt protocol; Assigned to Arm(s): Group II Control
D: Arm Label: Post Isometric Relaxation; Type: EXPERIMENTAL; Interventions: Other: 1.Post Isometric Relaxation | Arm Label: Myofascial Release Therapy; Type: EXPERIMENTAL; Interventions: Other: 1.Myofascial Release therapy | Intervention Type: OTHER; Name: 1.Post Isometric Relaxation; Assigned to Arm(s): Post Isometric Relaxation | Intervention Type: OTHER; Name: 1.Myofascial Release therapy; Assigned to Arm(s): Myofascial Release Therapy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safeguarding the Brains of Our Smallest Children - a Pilot Study
Brief Summary: Regional tissue oxygenation (rStO2) can be monitored by near-infrared spectroscopy. The investigators planned a SafeBoosC phase II trial to test if a reduction of the burden of hyper- and hypoxia can be accomplished during the first three days of life in infants born before 28 completed weeks of gestation. The investigators developed a treatment guideline and a randomised trial design to evaluate if cerebral rStO2 spent out of range in %hours can be reduced by 50%. The present trial is a non-randomised pilot study of the intervention in 10 infants.


Options:
A: Arm Label: Surfactant and Low Oxygen; Type: EXPERIMENTAL; Interventions: Drug: Surfactant, Drug: Supplemental oxygen with target saturation of 85 to 89% | Arm Label: Surfactant and High Oxygen; Type: EXPERIMENTAL; Interventions: Drug: Surfactant, Drug: Supplemental oxygen with target saturation of 91 to 95% | Arm Label: CPAP and Low Oxygen; Type: EXPERIMENTAL; Interventions: Device: Continuous Positive Airway Pressure (CPAP), Drug: Supplemental oxygen with target saturation of 85 to 89% | Arm Label: CPAP and High Oxygen; Type: EXPERIMENTAL; Interventions: Device: Continuous Positive Airway Pressure (CPAP), Drug: Supplemental oxygen with target saturation of 91 to 95% | Intervention Type: DRUG; Name: Surfactant; Assigned to Arm(s): Surfactant and High Oxygen, Surfactant and Low Oxygen | Intervention Type: DEVICE; Name: Continuous Positive Airway Pressure (CPAP); Assigned to Arm(s): CPAP and High Oxygen, CPAP and Low Oxygen | Intervention Type: DRUG; Name: Supplemental oxygen with target saturation of 85 to 89%; Assigned to Arm(s): CPAP and Low Oxygen, Surfactant and Low Oxygen | Intervention Type: DRUG; Name: Supplemental oxygen with target saturation of 91 to 95%; Assigned to Arm(s): CPAP and High Oxygen, Surfactant and High Oxygen
B: Arm Label: Cerebral NIRS oximetry + treatment guideline based on reading; Type: EXPERIMENTAL; Interventions: Device: Cerebral NIRS oximetry | Arm Label: Blinded cerebral NIRS oximetry; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Cerebral NIRS oximetry; Assigned to Arm(s): Cerebral NIRS oximetry + treatment guideline based on reading
C: Arm Label: cerebral oximetry + treatment guideline; Type: EXPERIMENTAL; Interventions: Device: cerebral oximeter | Intervention Type: DEVICE; Name: cerebral oximeter; Assigned to Arm(s): cerebral oximetry + treatment guideline
D: Arm Label: Near Infrared Spectroscopy; Type: EXPERIMENTAL; Interventions: Device: Near Infrared Spectroscopy | Arm Label: Pulse-oximetry; Type: OTHER; Interventions: Device: Pulse-oximetry | Intervention Type: DEVICE; Name: Near Infrared Spectroscopy; Assigned to Arm(s): Near Infrared Spectroscopy | Intervention Type: DEVICE; Name: Pulse-oximetry; Assigned to Arm(s): Pulse-oximetry

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Ovarian Hyperstimulation Syndrome in GnRH Agonist IVF Cycles: Randomized Study Comparing Hydroxyethyl Starch Versus Cabergoline and Hydroxyethyl Starch
Brief Summary: The purpose of this study is to assess whether, in GnRH agonist in vitro fertilization (IVF) cycles, where there is a risk of ovarian hyperstimulation syndrome (OHSS), the addition of cabergoline to the hydroxyethyl starch infusion could decrease OHSS incidence and severity.


Options:
A: Arm Label: Hemoes; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Cabergoline; Type: EXPERIMENTAL; Interventions: Drug: Cabergoline and Hydroxyethyl Starch, Drug: Hydroxyethyl Starch | Intervention Type: DRUG; Name: Cabergoline and Hydroxyethyl Starch; Assigned to Arm(s): Cabergoline | Intervention Type: DRUG; Name: Hydroxyethyl Starch; Assigned to Arm(s): Cabergoline
B: Arm Label: Coasting; Type: ACTIVE_COMPARATOR; Interventions: Procedure: ICSI | Arm Label: Cabergoline; Type: ACTIVE_COMPARATOR; Interventions: Procedure: ICSI | Arm Label: Coasting and Cabergoline; Type: ACTIVE_COMPARATOR; Interventions: Procedure: ICSI | Intervention Type: PROCEDURE; Name: ICSI; Assigned to Arm(s): Cabergoline, Coasting, Coasting and Cabergoline
C: Arm Label: Cabergoline group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cabergoline | Arm Label: GnRH antagonist rescue & cabergoline group; Type: EXPERIMENTAL; Interventions: Drug: GnRH antagonist rescue & cabergoline | Intervention Type: DRUG; Name: Cabergoline; Assigned to Arm(s): Cabergoline group | Intervention Type: DRUG; Name: GnRH antagonist rescue & cabergoline; Assigned to Arm(s): GnRH antagonist rescue & cabergoline group
D: Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Drug: Control | Arm Label: Cabergoline; Type: EXPERIMENTAL; Interventions: Drug: Cabergoline | Intervention Type: DRUG; Name: Cabergoline; Assigned to Arm(s): Cabergoline | Intervention Type: DRUG; Name: Control; Assigned to Arm(s): Control

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Ovarian Hyperstimulation Syndrome in GnRH Agonist IVF Cycles: Randomized Study Comparing Hydroxyethyl Starch Versus Cabergoline and Hydroxyethyl Starch
Brief Summary: The purpose of this study is to assess whether, in GnRH agonist in vitro fertilization (IVF) cycles, where there is a risk of ovarian hyperstimulation syndrome (OHSS), the addition of cabergoline to the hydroxyethyl starch infusion could decrease OHSS incidence and severity.


Options:
A: Arm Label: Cabergoline group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cabergoline | Arm Label: GnRH antagonist rescue & cabergoline group; Type: EXPERIMENTAL; Interventions: Drug: GnRH antagonist rescue & cabergoline | Intervention Type: DRUG; Name: Cabergoline; Assigned to Arm(s): Cabergoline group | Intervention Type: DRUG; Name: GnRH antagonist rescue & cabergoline; Assigned to Arm(s): GnRH antagonist rescue & cabergoline group
B: Arm Label: Hemoes; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Cabergoline; Type: EXPERIMENTAL; Interventions: Drug: Cabergoline and Hydroxyethyl Starch, Drug: Hydroxyethyl Starch | Intervention Type: DRUG; Name: Cabergoline and Hydroxyethyl Starch; Assigned to Arm(s): Cabergoline | Intervention Type: DRUG; Name: Hydroxyethyl Starch; Assigned to Arm(s): Cabergoline
C: Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Drug: Control | Arm Label: Cabergoline; Type: EXPERIMENTAL; Interventions: Drug: Cabergoline | Intervention Type: DRUG; Name: Cabergoline; Assigned to Arm(s): Cabergoline | Intervention Type: DRUG; Name: Control; Assigned to Arm(s): Control
D: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: Norprolac | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Norprolac | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Norprolac | Arm Label: 4; Type: EXPERIMENTAL; Interventions: Drug: Norprolac | Intervention Type: DRUG; Name: Norprolac; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Norprolac; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Norprolac; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: Norprolac; Assigned to Arm(s): 4

Answer: B